The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation

Molecular Biology of the Cell

Volumn 23, Issue 21, 2012, Pages 4212-4225

  Timmerman, Ilse ^a   Hoogenboezem, Mark ^a   Bennett, Anton M ^b   Geerts, Dirk ^c   Hordijk, Peter L ^a   Van Buul, Jaap D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; THROMBIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ELECTRIC RESISTANCE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CDC42 GTP-BINDING PROTEIN; CERCOPITHECUS AETHIOPS; COS CELLS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE SILENCING; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RAC1 GTP-BINDING PROTEIN; RHOA GTP-BINDING PROTEIN; SUBSTRATE SPECIFICITY; THROMBIN;

EID: 84868235288     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-01-0038     Document Type: Article

References (64)

1. Allingham MJ, Van Buul JD, Burridge K (2007). ICAM-1-mediated, Src-and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 179, 4053-4064.
2. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E (1999). Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 19, 2286-2297. (Pubitemid 29477828)
3. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE (2006). TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291, L1232-L1245. (Pubitemid 44904530)
4. Araki T, Nawa H, Neel BG (2003). Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 278, 41677-41684. (Pubitemid 37310425)
5. Balsamo J, Leung T, Ernst H, Zanin MK, Hoffman S, Lilien J (1996). Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin. J Cell Biol 134, 801-813. (Pubitemid 26271335)
6. Beckers CM, Van Hinsbergh VW, Van Nieuw Amerongen GP (2010). Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103, 40-55.
7. Bregeon J, Loirand G, Pacaud P, Rolli-Derkinderen M (2009). Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol 297, C1062-C1070.
8. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E (1995). Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb Vasc Biol 15, 1229-1239.
9. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ (2005). VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105, 2771-2776. (Pubitemid 40446268)
10. Daniel JM, Reynolds AB (1997). Tyrosine phosphorylation and cadherin/catenin function. Bioessays 19, 883-891. (Pubitemid 27447196)
11. Daum G, Solca F, Diltz CD, Zhao Z, Cool DE, Fischer EH (1993). A general peptide substrate for protein tyrosine phosphatases. Anal Biochem 211, 50-54. (Pubitemid 23189328)
12. Davis MA, Ireton RC, Reynolds AB (2003). A core function for p120-catenin in cadherin turnover. J Cell Biol 163, 525-534. (Pubitemid 37429866)
13. Dejana E, Orsenigo F, Lampugnani MG (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121, 2115-2122.
14. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72, 8463-8471. (Pubitemid 28471781)
15. Ellerbroek SM, Wennerberg K, Arthur WT, Dunty JM, Bowman DR, DeMali KA, der C, Burridge K (2004). SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis. Mol Biol Cell 15, 3309-3319. (Pubitemid 38850125)
16. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111, 1853-1865. (Pubitemid 28370530)
17. Ferber A, Yaen C, Sarmiento E, Martinez J (2002). An octapeptide in the juxtamembrane domain of VE-cadherin is important for p120ctn binding and cell proliferation. Exp Cell Res 274, 35-44.
18. Grinnell KL, Casserly B, Harrington EO (2010). Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 298, L361-L370.
19. Hellmuth K, Grosskopf S, Lum CT, Wurtele M, Roder N, von Kries J P, Rosario M, Rademann J, Birchmeier W (2008). Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc Natl Acad Sci USA 105, 7275-7280. (Pubitemid 351754468)
20. Hope TJ, Huang XJ, McDonald D, Parslow TG (1990). Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci USA 87, 7787-7791.
21. Hudry-Clergeon H, Stengel D, Ninio E, Vilgrain I (2005). Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. FASEB J 19, 512-520. (Pubitemid 40471242)
22. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C (1997). Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272, 843-851. (Pubitemid 27034572)
23. Kemler R (1993). From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9, 317-321. (Pubitemid 23271755)
24. Kolli S, Zito CI, Mossink MH, Wiemer EA, Bennett AM (2004). The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 279, 29374-29385. (Pubitemid 38915816)
25. Konstantoulaki M, Kouklis P, Malik AB (2003). Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. Am J Physiol Lung Cell Mol Physiol 285, L434-L442. (Pubitemid 36909460)
26. Kontaridis MI, Eminaga S, Fornaro M, Zito CI, Sordella R, Settleman J, Bennett AM (2004). SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol Cell Biol 24, 5340-5352. (Pubitemid 38738169)
27. Kouklis P, Konstantoulaki M, Vogel S, Broman M, Malik AB (2004). Cdc42 regulates the restoration of endothelial barrier function. Circ Res 94, 159-166. (Pubitemid 38197447)
28. Lacalle RA, Mira E, Gomez-Mouton C, Jimenez-Baranda S, Martinez A, Manes S (2002). Specific SHP-2 partitioning in raft domains triggers integrin-mediated signaling via Rho activation. J Cell Biol 157, 277-289. (Pubitemid 34839824)
29. Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E (1997). Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci 110, 2065-2077. (Pubitemid 27440430)
30. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, Dejana E (1995). The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129, 203-217.
31. Lee SW et al. (2011). Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-beta1/ERK/caspase-9 phosphorylation cascade. Mol Med 17, 1095-1106.
32. Lilien J, Balsamo J (2005). The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 17, 459-465. (Pubitemid 41267159)
33. Lu W, Gong D, Bar-Sagi D, Cole PA (2001). Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 8, 759-769. (Pubitemid 33030210)
34. Matsuyoshi N, Toda K, Horiguchi Y, Tanaka T, Nakagawa S, Takeichi M, Imamura S (1997). In vivo evidence of the critical role of cadherin-5 in murine vascular integrity. Proc Assoc Am Physicians 109, 362-371. (Pubitemid 27287734)
35. Mehta D, Malik AB (2006). Signaling mechanisms regulating endothelial permeability. Physiol Rev 86, 279-367.
36. Monaghan-Benson E, Burridge K (2009). The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284, 25602-25611.
37. Muller WA (2001). Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation. 8, 181-193. (Pubitemid 33612412)
38. Nakamura Y et al. (2008). Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 102, 1182-1191.
39. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E (1995). Catenin-dependent and-independent functions of vascular endothelial cadherin. J Biol Chem 270, 30965-30972. (Pubitemid 26012181)
40. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D (2002). VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 21, 4885-4895.
41. Neel BG, Gu H, Pao L (2003). The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28, 284-293. (Pubitemid 36776291)
42. Nottebaum AF et al. (2008). VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 205, 2929-2945.
43. Potter MD, Barbero S, Cheresh DA (2005). Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280, 31906-31912. (Pubitemid 41291941)
44. Price LS, Langeslag M, ten Klooster J P, Hordijk PL, Jalink K, Collard JG (2003). Calcium signaling regulates translocation and activation of Rac. J Biol Chem 278, 39413-39421. (Pubitemid 37248496)
45. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E (1996). Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 16, 488-496. (Pubitemid 26084325)
46. Ren XD, Kiosses WB, Schwartz MA (1999). Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18, 578-585. (Pubitemid 29057242)
47. Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM (2006). Genomescale loss-of-function screening with a lentiviral RNAi library. Nat Methods 3, 715-719. (Pubitemid 44275739)
48. Roura S, Miravet S, Piedra J, García de Herreros A, Duñach M (1999). Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 274, 36734-36740.
49. Schoenwaelder SM, Petch LA, Williamson D, Shen R, Feng GS, Burridge K (2000). The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Curr Biol 10, 1523-1526. (Pubitemid 32003645)
50. Sui XF et al. (2005). Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 166, 1247-1258. (Pubitemid 40524447)
51. ten Klooster J P, Jaffer ZM, Chernoff J, Hordijk PL (2006). Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix. J Cell Biol 172, 759-769.
52. Turowski P et al. (2008). Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci 121, 29-37. (Pubitemid 351265700)
53. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ (2000). SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 275, 5983-5986. (Pubitemid 30115248)
54. Ukropec JA, Hollinger MK, Woolkalis MJ (2002). Regulation of VE-cadherin linkage to the cytoskeleton in endothelial cells exposed to fluid shear stress. Exp Cell Res 273, 240-247. (Pubitemid 34920674)
55. Van Hinsbergh VW, Van Nieuw Amerongen G (2002). Intracellular signalling involved in modulating human endothelial barrier function. J Anat 200, 549-560. (Pubitemid 34823047)
56. Vincent PA, Xiao K, Buckley KM, Kowalczyk AP (2004). VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 286, C987-C997. (Pubitemid 38506914)
57. Wang D, Paria BC, Zhang Q, Karpurapu M, Li Q, Gerthoffer WT, Nakaoka Y, Rao GN (2009). A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis. Circ Res 104, 1066-1075.
58. Weis SM, Cheresh DA (2005). Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437, 497-504. (Pubitemid 41613541)
59. Winter MC, Shasby S, Shasby DM (2008). Compromised E-cadherin adhesion and epithelial barrier function with activation of G protein-coupled receptors is rescued by Y-to-F mutations in beta-catenin. Am J Physiol Lung Cell Mol Physiol 294, L442-L448. (Pubitemid 351468844)
60. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, Faundez V, Kowalczyk AP (2003). Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol 163, 535-545. (Pubitemid 37429867)
61. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, Faundez V, Kowalczyk AP (2005). p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell 16, 5141-5151. (Pubitemid 41566827)
62. Xiao K, Oas RG, Chiasson CM, Kowalczyk AP (2007). Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta 1773, 8-16. (Pubitemid 44914097)
63. Young BA et al. (2003). Protein tyrosine phosphatase activity regulates endothelial cell-cell interactions, the paracellular pathway, and capillary tube stability. Am J Physiol Lung Cell Mol Physiol 285, L63-L75. (Pubitemid 36736469)
64. Zhang ZY, Thieme-Sefler AM, MacLean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE (1993). Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci USA 90, 4446-4450. (Pubitemid 23148921)